Skip to content
It's time to build
Nav Opener
  • Portfolio
  • Team
  • Focus Areas
    • American Dynamism
    • Bio + Health
    • Cultural Leadership Fund
    • Consumer
    • Crypto
    • Enterprise
    • Fintech
    • Games
    • Growth
    • Talent x Opportunity
  • Content
    Topics
    • Bio + Health
    • Consumer
    • Creator Economy
    • Marketplaces
    • Gaming & Social
    • Fintech
    • Enterprise & SaaS
    • Security & Privacy
    • Cryptocurrencies & Blockchains
    Type
    • Articles
    • Video
    • Podcasts
    • Newsletters
  • About
  • Jobs
  • Newsletters
Close

Andy Tran

Andy is a partner on the bio investment team, where he focuses on companies at the intersection of biology, engineering, and healthcare.

Prior to joining a16z, Andy worked in Genentech’s Discovery Oncology department, where he developed high-throughput, genome-wide screens and computational tools for identifying novel cancer targets. Before that, Andy worked with Professor George Church at the Harvard Medical School/Wyss Institute, where he engineered CRISPR genome editing technologies for therapeutic applications. Andy also analyzed high-growth technology companies in the investment banking division of Morgan Stanley.

Andy studied Bioengineering and Computer Science at Harvard University, where he focused on genomics and machine learning. He was awarded the First Place Grand Award in Medicine at the Intel International Science and Engineering Fair.

While not searching for the next frontier in bio, Andy enjoys playing the guitar, building computers, and swimming.

Latest Posts

Journal Club: Slaying the Sleeper Cells of Aging

by Jorge Conde, Andy Tran, and Lauren Richardson
  • bio + health
  • a16z Journal Club
  • therapeutics

Evaluating AI in Bio: How to Know Whether it is Worth the Work

by Andy Tran and Vijay Pande
  • AI, machine & deep learning
  • bio + health
  • AI in bio

Platform-Disease Fit: Why You Need It and How to Find It

by Andy Tran and Jorge Conde
  • bio + health
  • building a bio company
  • Company Building 101
  • the bio platforms playbook
  • therapeutics

Journal Club: Turning a Toxin into a Genome Editing Tool

by Jorge Conde, Andy Tran, and Lauren Richardson
  • bio + health
  • a16z Journal Club
  • gene editing including CRISPR
  • when science becomes engineering

From @andy23tran

Andy Tran@andy23tran

Re-reading books is definitely highly underrated. There are many books where each re-read, opens up profound new meaning. This is especially true after you gain new life experiences and revisit the journey. Sometimes upon rereads I realized I didn't truly "get it" 💡 before https://t.co/yJajdJAxWi

Andy Tran@andy23tran

Too many people read books, but do nothing. Read enough to get the inspiration. Then go do. Try, build, experiment, fail, retry, rinse and repeat. If you get stuck on something granular or need a spark then go target some books. Read with intention, not for procrastination. https://t.co/sewSVbq1b1

Andy Tran@andy23tran

Despite the turbulence in the broader economy, 2022 was one of the most jampacked and mindblowing years in science, tech, and medicine. Top breakthroughs from this year that are poised to transform industries and our understanding of humanity for 2023 and beyond : https://t.co/RlkpF8P0pS

Software is eating the world
© 2023 Andreessen Horowitz
Software is eating the world
    • Twitter
    • Simplecast
  • Contact
  • Jobs
  • Briefings
  • Terms of Use & Privacy
  • Disclosures
  • Conduct
  • Who We Are